Pharmacogenetics in immunosuppressive therapy: the best thing since TDM?

Ther Drug Monit. 2004 Aug;26(4):343-6. doi: 10.1097/00007691-200408000-00001.
No abstract available

Publication types

  • Review

MeSH terms

  • Clinical Trials as Topic
  • Dose-Response Relationship, Drug
  • Drug Monitoring*
  • Humans
  • Immunosuppressive Agents / administration & dosage
  • Immunosuppressive Agents / pharmacokinetics*
  • Pharmacogenetics*

Substances

  • Immunosuppressive Agents